National Institutes of Health

Biomedical research funded by the National Institutes of Health (NIH) and performed at research universities helps assure U.S. leadership in the life sciences revolution of the 21st Century. Putting NIH on a sustained pathway to restore its purchasing power after a decade worth of loss to inflation and budget cuts is critical to sustaining the extraordinary progress in the improvement of human health of the past decades. Investment in NIH will continue to create jobs and strengthen the workforce, improve the lives—and quality of life—of millions of current and future patients, and help assure continuing U.S. economic and national security.

Sustained investment in biotechnology and genomics is crucial to the development of novel therapies for diseases, including: cancer, Alzheimer's, autism, and diabetes. The NIH also responds rapidly to public health emergencies and in support of biodefense, such as in the case of Ebola, Zika, and COVID-19.

AAU Urges Labor-HHS-Ed Conferees to Adopt Senate NIH, Pell, IES Funding Levels

AAU President Mary Sue Coleman sent a letter to House and Senate Appropriators urging them to adopt the Senate-passed funding levels for the National Institutes of Health (NIH) and for the maximum Pell Grant.

September 11, 2018

The Ad Hoc Group for Medical Research Recommends $39.3 billion in FY19 Funding for NIH

The Ad Hoc Group for Medical Research, of which AAU is a member, wrote to Congress recommending members appropriate $39.3 billion in FY 2019 for National Institutes of Health (NIH).

Letters | FY19 | National Institutes of Health

April 30, 2018

National Institutes of Health (NIH) AAU FY19 Funding Brief

AAU urges Congress to provide at least $39.3 billion for the National Institutes of Health (NIH) in FY19.

Fact Sheets | Federal Budget | FY19 | National Institutes of Health

April 6, 2018

AAU Summary of FY18 Omnibus Package

This document summarizes the FY18 Omnibus funding bill for federal agencies and programs of interest to research universities.

March 23, 2018

AAU FY18 Funding Priorities Table

Status of FY18 appropriations including House and Senate allocations for AAU's funding priorities.

March 22, 2018

AAU Summary of the President's FY19 Proposed Budget

An overview of the President's proposed budget for FY19, including summaries and analyses for individual agencies.

February 12, 2018

Associations Ask NIH to Clarify Policies on Genomic Data Sharing

AAU, APLU, and COGR submitted a letter to NIH in response to the agency’s Request for Comments on its Proposal to Update Data Management of Genomic Summary Results Under the NIH Genomic Data Sharing Policy. The joint letter requests NIH clarify that the consent requirements detailed in the notice are limited to prospective collections and agrees that summary genomic data results should be provided through appropriate controlled access.

Letters | National Institutes of Health

October 24, 2017

Patient and Research Community Letter on Fetal Tissue and Embryonic Stem Cell Research Funding

Over 60 organizations, including the Association of American Universities, wrote to Senate leaders opposing prohibitions or restrictions that would further impede the use of federal funding for fetal tissue or embryonic stem cell research.

Letters | Research Administration & Regulation | National Institutes of Health

August 28, 2017

Research Community Letter to OMB Director Mulvaney and HHS Secretary Price on Facilities and Administrative Costs Reimbursements

AAU joined 108 national research organizations to oppose cuts to NIH funding and facilities and administrative (F&A) reimbursements in the Administration's FY18 budget.

Letters | Costs of Research (F&A Costs) | FY18 | National Institutes of Health

August 21, 2017

FY18 Coalition Letter Calls for a Bipartisan Budget Agreement

Multiple coalitions urged members of the 115th Congress to pass a bipartisan budget agreement that increases the spending caps for both defense and non-defense discretionary programs.

July 18, 2017